
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1013 | 1009 | 1178 | 817 | 1102 | 1177 |
Fund Return | 1.28% | 0.94% | 17.79% | -6.51% | 1.97% | 1.64% |
Place in category | 368 | 254 | 224 | 155 | 157 | 58 |
% in Category | 56 | 41 | 36 | 39 | 60 | 79 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Soochow Mobile Internet mix A | 4.69B | 7.04 | 13.52 | - | ||
Soochow Mobile Internet mix C | 4.69B | 7.00 | 13.29 | - | ||
Soochow AnYing Quantity Alloc Fd | 672.98M | 2.16 | -1.08 | - | ||
Soochow New Trend Value mix | 561.47M | 8.66 | 14.73 | - | ||
Soochow Jiahe Advanced Mixed | 448.56M | 8.54 | 8.70 | 2.94 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Zhong Ou Modern Pioneer InitiatingA | 11.32B | 2.97 | -8.18 | - | ||
TianHong ChiNext Index A | 9.8B | 1.24 | -7.98 | - | ||
TianHong ChiNext Index C | 9.8B | 1.20 | -8.16 | - | ||
ICBC Credit Literary Ids Eq | 5.6B | 7.24 | -1.38 | - | ||
Harvest Emerging Industry Eq | 5.17B | 1.68 | -10.08 | 10.23 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Amperex Tech A | CNE100003662 | 7.72 | 249.14 | +0.03% | |
BYD A | CNE100001526 | 4.02 | 360.50 | -1.37% | |
Luxshare Precision A | CNE100000TP3 | 3.17 | 39.35 | -2.70% | |
Shenzhen Mindray Bio-Medical | CNE100003G67 | 2.81 | 229.86 | -2.87% | |
Jiangsu Hengrui | CNE0000014W7 | 2.59 | 50.85 | -1.83% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review